STOCK TITAN

Acutus Medical to Announce Third Quarter 2023 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Acutus Medical, Inc. will release its third quarter 2023 financial results on November 13, 2023. A conference call and webcast will be held to discuss the results and recent highlights. Participants can access the live call via telephone or the Acutus investor relations website. A replay of the webinar will be available on the company's website.
Positive
  • None.
Negative
  • None.

CARLSBAD, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its third quarter 2023 financial results on Monday, November 13, 2023. In conjunction with the release, Acutus will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

To access the live call via telephone, please register in advance using the link here. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique personal PIN that can be used to join the call.

The live webinar of the call may be accessed by visiting the Events section of the Acutus investor relations website at ir.acutusmedical.com. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on the company’s website.

About Acutus Medical, Inc.
Acutus is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Acutus is committed to advancing the field of electrophysiology with a unique array of products and technologies which will enable more physicians to treat more patients more efficiently and effectively. Through internal product development, acquisitions and global partnerships, Acutus has established a global sales presence delivering a broad portfolio of highly differentiated electrophysiology products that provide its customers with a complete solution for catheter-based treatment of cardiac arrhythmias. Founded in 2011, Acutus is based in Carlsbad, California.

Investor Contact: 
Chad Hollister
 
Acutus Medical, Inc. 
D: 442-232-6080 
investors@acutus.com


Acutus Medical will release its third quarter 2023 financial results on November 13, 2023.

The conference call and webcast will discuss Acutus Medical's financial results and recent highlights.

Participants can access the live call via telephone or the Acutus investor relations website.

Yes, a replay of the webinar will be available on the company's website.
Acutus Medical Inc

NASDAQ:AFIB

AFIB Rankings

AFIB Latest News

AFIB Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Distribution Services, Medical Distributors, Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing

About AFIB

world class talent with the mission to reshape ep acutus medical has attracted some of the most respected pioneers and leaders in electrophysiology and cardiac device manufacturing to join our organization and our worldwide network of collaborative partners. the common bond that brings us together is our passion and collective capability to revolutionize a field that has not seen major technological advances in decades. our mission of continual innovation is focused on providing electrophysiologists with the highest quality suite of tools, coupled with outstanding clinical and technical support, to better understand and effectively treat complex arrhythmias. electrophysiology is a high growth market with a clear need for a leap-frog technology to address the unmet need for a scientific, medical evidence-based approach to treating atrial fibrillation, ventricular tachycardia and the other complex arrhythmia's. acutus medical is a full-portfolio solution provider for treating these patie